Track Vesugen in Peptimes™
Vesugen is a peptide of three amino acids: Lys-Glu-Asp (lysyl-glutamyl-aspartic acid). NLM's MeSH also lists it as tripeptide T-38. (Source: NLM MeSH.)
Is Vesugen FDA-approved?
No. Vesugen isn't FDA-approved, and Drugs@FDA lists no application with it as an active ingredient.
Vesugen
Also: KED, Lys-Glu-Asp, lysyl-glutamyl-aspartic acid, tripeptide T-38
- Status label in the Peptimes Library
- Not FDA-Approved
- Routes in Peptimes
- SubcutaneousIntramuscularOralSublingualNasalTopicalOther
- Updated
- 1 Nov 2026
US regulatory status
How to track it in Peptimes
Add Vesugen in My Protocols and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose. Its Library entry shows the status label “Not FDA-Approved”.
- Routes: the app lets you record whichever route you used; none is established. Its routes are subcutaneous, intramuscular, oral, sublingual, nasal, topical and Other.
- Logging: the amount you took, the route and how you feel.
- Injection sites: subcutaneous and intramuscular doses record the site, and Insights shows where you’ve injected and how recently. It never suggests where to inject next. Other routes skip this step.
- Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.
Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell Vesugen or any other compound.
More sources
- US National Library of Medicine, MeSH, lysyl-glutamyl-aspartic acid, checked 1 Nov 2026: a supplementary substance record with the names vesugen, Lys-Glu-Asp and tripeptide T-38.
- FDA, Drugs@FDA, checked 1 Nov 2026: no application lists vesugen or Lys-Glu-Asp as an active ingredient.